Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression

Por Moertel, Christopher, Xi, Junzhe, Olin, Michael R
Publicado em 2013

CD8(+) T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity

Por Pluhar, G. Elizabeth, Pennell, Christopher A., Olin, Michael R.
Publicado no Crit Rev Immunol (2015)

Morphine Induces Splenocyte Trafficking into the CNS

Por Olin, Michael R, Oh, Seunguk, Roy, Sabita, Peterson, Phillip K, Molitor, Thomas
Publicado em 2011

γδ T Cells in Immunity Induced by Mycobacterium bovis Bacillus Calmette-Guérin Vaccination

Por Lee, Jinhee, Choi, Keumhwa, Olin, Michael R., Cho, Sang-Nae, Molitor, Thomas W.
Publicado em 2004

Victory and Defeat in the Induction of a Therapeutic Response through Vaccine Therapy for Human and Canine Brain Tumors: A Review of the State of the Art

Por Olin, Michael R., Pluhar, G. Elizabeth, Andersen, Brian M., Shaver, Rob, Waldron, Nate N., Moertel, Christopher L.
Publicado no Crit Rev Immunol (2014)

Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant

Por Andersen, Brian M., Xia, Junzhe, Epstein, Alan L., Ohlfest, John R., Chen, Wei, Blazar, Bruce R., Pennell, Christopher A., Olin, Michael R.
Publicado no J Immunother Cancer (2016)

Vaccine Injection Site Matters: Qualitative and Quantitative Defects in CD8 T Cells Primed as a Function of Proximity to the Tumor in a Murine Glioma Model

Por Ohlfest, John R., Andersen, Brian M., Litterman, Adam J., Junzhe, Xia, Pennell, Christopher A., Swier, Lauryn E., Salazar, Andres M., Olin, Michael R.
Publicado em 2012

Oxygen is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells

Por Olin, Michael R., Andersen, Brian M., Litterman, Adam J., Grogan, Patrick T., Sarver, Aaron, Robertson, Paul T., Liang, Xueqing, Chen, Wei, Parney, Ian F., Hunt, Matthew A., Blazar, Bruce R., Ohlfest, John R.
Publicado em 2011

Superior Efficacy of Tumor Cell Vaccines Grown In Physiologic Oxygen

Por Olin, Michael R., Andersen, Brian M., Zellmer, David M., Grogan, Patrick T., Popescu, Flavia E., Xiong, Zhengming, Forster, Colleen L., Seiler, Charlie, SantaCruz, Karen S., Chen, Wei, Blazar, Bruce R., Ohlfest, John R.
Publicado em 2010

Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response

Por Olin, Michael R, Low, Walter, McKenna, David H, Haines, Stephen J, Dahlheimer, Tambra, Nascene, David, Gustafson, Michael P, Dietz, Allan B, Clark, H Brent, Chen, Wei, Blazar, Bruce, Ohlfest, John R, Moertel, Christopher
Publicado em 2014

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy

Por Moertel, Christopher L, Xia, Junzhe, LaRue, Rebecca, Waldron, Nate N, Andersen, Brian M, Prins, Robert M, Okada, Hideho, Donson, Andrew M, Foreman, Nicholas K, Hunt, Matthew A, Pennell, Christopher A, Olin, Michael R
Publicado no J Immunother Cancer (2014)

An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas

Por Murphy, Katherine A., Lechner, Melissa G., Popescu, Flavia E., Bedi, Jessica, Decker, Stacy A., Hu, Peisheng, Erickson, Jami R., O’Sullivan, M. Gerard, Swier, Lauryn, Salazar, Andres M., Olin, Michael R., Epstein, Alan L., Ohlfest, John R.
Publicado em 2012